N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141859 |
| CAS No | NA |
| Mol.F. | C14H20FN5O7 |
| Mol.Wt. | 389.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141860 |
| CAS No | 38652-29-8 |
| Mol.F. | C14H10N2O |
| Mol.Wt. | 222.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141861 |
| CAS No | 7458-08-4 |
| Mol.F. | C14H12N2O |
| Mol.Wt. | 224.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141862 |
| CAS No | NA |
| Mol.F. | C15H16ClN3O2 |
| Mol.Wt. | 305.8 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141863 |
| CAS No | NA |
| Mol.F. | C16H23N3O4 |
| Mol.Wt. | 321.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141864 |
| CAS No | NA |
| Mol.F. | C14H30N2O6 |
| Mol.Wt. | 322.40 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141865 |
| CAS No | NA |
| Mol.F. | C16H20N2O4 |
| Mol.Wt. | 304.25 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141866 |
| CAS No | NA |
| Mol.F. | C16H18N2O5 |
| Mol.Wt. | 318.33 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141867 |
| CAS No | NA |
| Mol.F. | C19H21N3O |
| Mol.Wt. | 307.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141868 |
| CAS No | NA |
| Mol.F. | C17H17N3O3 |
| Mol.Wt. | 311.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141869 |
| CAS No | NA |
| Mol.F. | C14H13N3O2 |
| Mol.Wt. | 255.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141870 |
| CAS No | NA |
| Mol.F. | C30H35N5O4 |
| Mol.Wt. | 529.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141871 |
| CAS No | NA |
| Mol.F. | C30H33N5O4 |
| Mol.Wt. | 527.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141872 |
| CAS No | NA |
| Mol.F. | C13H13N3O4 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141873 |
| CAS No | 18600-49-2 |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.19 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141874 |
| CAS No | NA |
| Mol.F. | C25H26IN3O3 |
| Mol.Wt. | 543.4 |
| INV STATUS | In Stock |